ArticleArthritis research & therapy2015

CDP7657, an anti-CD40L antibody lacking an Fc domain, inhibits CD40L-dependent immune responses without thrombotic complications: an in vivo study.

Anthony Shock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.